http://dbpedia.org/ontology/abstract
|
3F-NEH (3-Fluoro-N-Ethylhexedrone) is a recreational designer drug from the substituted cathinone family, with stimulant effects. It was first identified in Sweden in October 2020.
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/3F-NEH.svg?width=300 +
|
http://dbpedia.org/ontology/wikiPageID
|
68542362
|
http://dbpedia.org/ontology/wikiPageLength
|
1620
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1125007398
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/3F-Phenmetrazine +
, http://dbpedia.org/resource/N-Ethylhexylone +
, http://dbpedia.org/resource/Stimulant +
, http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Substituted_cathinone +
, http://dbpedia.org/resource/Category:Serotonin-norepinephrine-dopamine_releasing_agents +
, http://dbpedia.org/resource/Designer_drug +
, http://dbpedia.org/resource/Category:Cathinones +
, http://dbpedia.org/resource/Category:Fluoroarenes +
, http://dbpedia.org/resource/3-Fluoromethcathinone +
, http://dbpedia.org/resource/3F-PiHP +
, http://dbpedia.org/resource/3F-PVP +
, http://dbpedia.org/resource/3F-NEB +
, http://dbpedia.org/resource/N-Ethylhexedrone +
, http://dbpedia.org/resource/3-Fluoromethamphetamine +
|
http://dbpedia.org/property/c
|
14
|
http://dbpedia.org/property/f
|
1
|
http://dbpedia.org/property/h
|
20
|
http://dbpedia.org/property/iupacName
|
2
|
http://dbpedia.org/property/n
|
1
|
http://dbpedia.org/property/o
|
1
|
http://dbpedia.org/property/smiles
|
O=CCNCC
|
http://dbpedia.org/property/width
|
220
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
, http://dbpedia.org/resource/Template:Stimulants +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Drugbox +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Category:Cathinones +
, http://dbpedia.org/resource/Category:Fluoroarenes +
, http://dbpedia.org/resource/Category:Serotonin-norepinephrine-dopamine_releasing_agents +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/3F-NEH?oldid=1125007398&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/3F-NEH.svg +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/3F-NEH +
|
owl:sameAs |
http://www.wikidata.org/entity/Q108226337 +
, http://dbpedia.org/resource/3F-NEH +
, https://global.dbpedia.org/id/FzUXm +
|
rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/ontology/Drug +
, http://www.wikidata.org/entity/Q8386 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
|
rdfs:comment |
3F-NEH (3-Fluoro-N-Ethylhexedrone) is a recreational designer drug from the substituted cathinone family, with stimulant effects. It was first identified in Sweden in October 2020.
|
rdfs:label |
3F-NEH
|